Almenoff June Sherie
SEC-identified person · CIK 1492647 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Tenax Therapeutics, INC. tenx | Director | filed 2021 - 2026 |
| Cerecor Inc. CERC | Director | filed 2021 - 2025 |
| Cactus Ventures, Inc. none | Director | filed 2024 - 2025 |
| Brainstorm Cell Therapeutics INC. BCLI] | Director | filed 2017 - 2021 |
| Monster Digital, Inc. NMTR | COO and Chief Medical Officer | filed 2018 - 2018 |
| Ohr Pharmaceutical Inc OHRP | Director | filed 2013 - 2017 |
| Furiex Pharmaceuticals, Inc. FURX | Director · President | filed 2010 - 2014 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.